newsfilter
← Latest News
PR Newswire·

Oncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myeloma

STOCKHOLM , Sept. 7, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ:ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the company has rece